Leonteq Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Leonteq Securities's BMRN Position: Q3 2026 in Review
Leonteq Securities reduced its BioMarin Pharmaceuticals (BMRN) stake by 38% in Q3 2026, selling an estimated $86.3K and leaving 2,227 shares worth $134K. The position accounts for 0.01% of the portfolio, ranked #601.
Leonteq Securities first reported a position in BMRN in Q4 2020 and has held it in 24 quarters since. The position peaked at $5.27M in Q1 2021. 565 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Leonteq Securities held 2,227 shares of BioMarin Pharmaceuticals worth $134K as of Q3 2026.
- Leonteq Securities sold 1,371 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $86.3K.
- BioMarin Pharmaceuticals made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #601 holding.
- Leonteq Securities first reported a position in BioMarin Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
- Leonteq Securities's BioMarin Pharmaceuticals position peaked at $5.27M in Q1 2021.
- 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.